By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anavex Life Sciences Corp. 

50 Harrison St.
Suite 315A
Hoboken  New Jersey  07030  U.S.A.
Phone: 416-489-0092 or 866-505-2895 Fax: n/a


SEARCH JOBS








Company News
Anavex Life Sciences Corp. (AVXL.OB) Announces Positive Phase 1 Data For ANAVEX 2-73, Lead Candidate For The Treatment Of Alzheimer's 11/17/2014 10:37:14 AM
Anavex Life Sciences Corp. (AVXL.OB) To Present Full Phase 1 Clinical Trial Data For ANAVEX 2-73 At CNS Summit 2014 Conference 11/10/2014 7:31:21 AM
Neuronetrix, Inc. Has Been Selected By Anavex Life Sciences Corp. (AVXL.OB) To Support The Upcoming Phase 2a Clinical Trial For ANAVEX 2-73 11/7/2014 8:27:43 AM
Anavex Life Sciences Corp. (AVXL.OB) To Present At SeeThruEquity Investor Conference In New York City 11/6/2014 1:06:01 PM
Anavex Life Sciences Corp. (AVXL.OB) Receives Regulatory Approval To Initiate Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS For Alzheimer's Disease 11/3/2014 7:27:13 AM
Institutional Investor Lincoln Park Capital Increases Ownership In Anavex Life Sciences Corp. (AVXL.OB), Pays Over 25% Premium To Market 10/27/2014 7:56:51 AM
Anavex Life Sciences Corp. (AVXL.OB) Supports Alzheimer's Foundation Of America's 3rd Annual Concepts In Care Educational Conference 9/8/2014 7:57:17 AM
Anavex Life Sciences Corp. (AVXL.OB) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/3/2014 7:45:20 AM
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial 8/26/2014 8:16:48 AM
Anavex Life Sciences Corp. (AVXL.OB) Reports That Antidepressant Fluvoxamine Reduces Stress Through Sigma-1 Receptor 8/19/2014 9:40:19 AM
12345678910...
//-->